Vault-13

DAFNA Capital Management LLC

LOS ANGELES, CA · CIK 1389933 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2003 · limited liability company

As an employer

$366.9m reported value -4.4% vs Q1 2022
90positions
47.4%in top 10
4 new 38 added 14 reduced 8 sold out vs Q1 2022

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SPDR SER TR S&P BIOTECH XBI XBI 613,000 $45.5m12.41% 12.41% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 269.5k, Q2 2022 613.0k +343.5k +343,500 127.5%
2 STEREOTAXIS INC COM NEW STXS STXS 13,680,554 $25.2m6.86% 6.86% UnchangedShares held: Q3 2021 13.7m, Q4 2021 13.7m, Q1 2022 13.7m, Q2 2022 13.7m
3 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 110,100 $16.0m4.37% 4.37% AddedShares held: Q3 2021 88.1k, Q4 2021 58.1k, Q1 2022 77.6k, Q2 2022 110.1k +32.5k +32,500 41.9%
4 ADICET BIO INC COM COM 935,766 $13.7m3.72% 3.72% AddedShares held: Q3 2021 376.3k, Q4 2021 733.2k, Q1 2022 715.9k, Q2 2022 935.8k +219.9k +219,894 30.7%
5 FATE THERAPEUTICS INC COM FATE FATE 550,940 $13.7m3.72% 3.72% AddedShares held: Q3 2021 344.4k, Q4 2021 372.2k, Q1 2022 500.9k, Q2 2022 550.9k +50.0k +50,010 10.0%
6 XENON PHARMACEUTICALS INC COM XENE XENE 438,623 $13.3m3.64% 3.64% AddedShares held: Q3 2021 406.5k, Q4 2021 402.7k, Q1 2022 380.2k, Q2 2022 438.6k +58.5k +58,460 15.4%
7 BLUEPRINT MEDICINES CORP COM BPMC BPMC 261,280 $13.2m3.60% 3.60% AddedShares held: Q3 2021 206.9k, Q4 2021 206.9k, Q1 2022 246.3k, Q2 2022 261.3k +15.0k +15,000 6.1%
8 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 139,212 $12.9m3.53% 3.53% AddedShares held: Q3 2021 0, Q4 2021 11.0k, Q1 2022 30.6k, Q2 2022 139.2k +108.6k +108,600 354.8%
9 ISHARES TR ISHARES BIOTECH IBB IBB 102,500 $12.1m3.29% 3.29% UnchangedShares held: Q3 2021 40.9k, Q4 2021 40.9k, Q1 2022 102.5k, Q2 2022 102.5k
10 CYTOKINETICS INC COM NEW CYTK CYTK 211,495 $8.3m2.26% 2.26% UnchangedShares held: Q3 2021 175.0k, Q4 2021 134.1k, Q1 2022 211.5k, Q2 2022 211.5k
11 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 82,655 $8.1m2.20% 2.20% ReducedShares held: Q3 2021 84.7k, Q4 2021 83.7k, Q1 2022 83.7k, Q2 2022 82.7k -1.0k -1,000 -1.2%
12 KARUNA THERAPEUTICS INC COM COM 62,053 $7.8m2.14% 2.14% ReducedShares held: Q3 2021 74.6k, Q4 2021 72.4k, Q1 2022 82.1k, Q2 2022 62.1k -20.0k -20,000 -24.4%
13 IDEAYA BIOSCIENCES INC COM IDYA IDYA 548,561 $7.6m2.06% 2.06% AddedShares held: Q3 2021 460.1k, Q4 2021 460.1k, Q1 2022 490.1k, Q2 2022 548.6k +58.5k +58,500 11.9%
14 NURIX THERAPEUTICS INC COM NRIX NRIX 566,695 $7.2m1.96% 1.96% AddedShares held: Q3 2021 306.3k, Q4 2021 306.3k, Q1 2022 543.3k, Q2 2022 566.7k +23.4k +23,351 4.3%
15 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 370,987 $7.1m1.95% 1.95% ReducedShares held: Q3 2021 80.7k, Q4 2021 296.5k, Q1 2022 372.0k, Q2 2022 371.0k -1.0k -1,000 -0.3%
16 MERUS N V COM MRUS MRUS 262,891 $6.0m1.62% 1.62% AddedShares held: Q3 2021 131.9k, Q4 2021 226.1k, Q1 2022 235.0k, Q2 2022 262.9k +27.9k +27,902 11.9%
17 REVOLUTION MEDICINES INC COM RVMD RVMD 299,785 $5.8m1.59% 1.59% AddedShares held: Q3 2021 209.7k, Q4 2021 212.2k, Q1 2022 232.1k, Q2 2022 299.8k +67.7k +67,684 29.2%
18 SAGE THERAPEUTICS INC COM SAGE SAGE 180,306 $5.8m1.59% 1.59% UnchangedShares held: Q3 2021 180.3k, Q4 2021 180.3k, Q1 2022 180.3k, Q2 2022 180.3k
19 ALECTOR INC COM ALEC ALEC 552,438 $5.6m1.53% 1.53% AddedShares held: Q3 2021 107.4k, Q4 2021 155.2k, Q1 2022 292.7k, Q2 2022 552.4k +259.7k +259,691 88.7%
20 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 695,959 $5.5m1.51% 1.51% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 356.8k, Q2 2022 696.0k +339.2k +339,209 95.1%
21 DEXCOM INC COM DXCM DXCM 72,552 $5.4m1.47% 1.47% UnchangedShares held: Q3 2021 84.6k, Q4 2021 72.6k, Q1 2022 72.6k, Q2 2022 72.6k
22 MIRATI THERAPEUTICS INC COM MRTX MRTX 79,600 $5.3m1.46% 1.46% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 42.7k, Q2 2022 79.6k +36.9k +36,900 86.4%
23 CYMABAY THERAPEUTICS INC COM CBAY CBAY 1,787,569 $5.3m1.44% 1.44% AddedShares held: Q3 2021 524.3k, Q4 2021 1.8m, Q1 2022 1.7m, Q2 2022 1.8m +95.0k +95,000 5.6%
24 ARCUS BIOSCIENCES INC COM RCUS RCUS 187,717 $4.8m1.30% 1.30% AddedShares held: Q3 2021 123.7k, Q4 2021 117.2k, Q1 2022 145.2k, Q2 2022 187.7k +42.5k +42,500 29.3%
25 NATUS MED INC DEL COM BABY BABY 143,600 $4.7m1.28% 1.28% ReducedShares held: Q3 2021 95.7k, Q4 2021 190.6k, Q1 2022 190.6k, Q2 2022 143.6k -47.0k -47,035 -24.7%
26 APELLIS PHARMACEUTICALS INC COM APLS APLS 96,935 $4.4m1.19% 1.19% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 93.9k, Q2 2022 96.9k +3.0k +3,000 3.2%
27 MORPHIC HLDG INC COM MORF MORF 195,467 $4.2m1.16% 1.16% AddedShares held: Q3 2021 181.5k, Q4 2021 181.5k, Q1 2022 181.5k, Q2 2022 195.5k +14.0k +14,000 7.7%
28 CARDIOVASCULAR SYS INC DEL COM CSII CSII 286,988 $4.1m1.12% 1.12% UnchangedShares held: Q3 2021 193.7k, Q4 2021 287.0k, Q1 2022 287.0k, Q2 2022 287.0k
29 CENTURY THERAPEUTICS INC COM IPSC IPSC 475,367 $4.0m1.09% 1.09% AddedShares held: Q3 2021 80.0k, Q4 2021 100.1k, Q1 2022 256.9k, Q2 2022 475.4k +218.5k +218,475 85.0%
30 RADIUS HEALTH INC NOTE 3.000% 9/0 · principal RDUS 3 09.01.24 · principal RDUS 3 09.01.24 4,000,000 $3.9m1.07% 1.07% UnchangedPrincipal held: Q3 2021 4.0m, Q4 2021 4.0m, Q1 2022 4.0m, Q2 2022 4.0m
31 IVERIC BIO INC COM OPHT OPHT 402,476 $3.9m1.06% 1.06% AddedShares held: Q3 2021 216.4k, Q4 2021 276.0k, Q1 2022 298.5k, Q2 2022 402.5k +104.0k +104,000 34.8%
32 TURNING POINT THERAPEUTICS I COM COM 48,452 $3.6m0.99% 0.99% ReducedShares held: Q3 2021 42.0k, Q4 2021 46.5k, Q1 2022 59.5k, Q2 2022 48.5k -11.0k -11,000 -18.5%
33 F-STAR THERAPEUTICS INC COM COM 576,881 $3.6m0.98% 0.98% ReducedShares held: Q3 2021 693.8k, Q4 2021 693.8k, Q1 2022 693.8k, Q2 2022 576.9k -116.9k -116,904 -16.9%
34 OTONOMY INC COM OTIC OTIC 1,470,199 $3.1m0.83% 0.83% ReducedShares held: Q3 2021 2.4m, Q4 2021 2.2m, Q1 2022 1.5m, Q2 2022 1.5m -27.3k -27,315 -1.8%
35 ATRICURE INC COM ATRC ATRC 72,029 $2.9m0.80% 0.80% UnchangedShares held: Q3 2021 72.0k, Q4 2021 72.0k, Q1 2022 72.0k, Q2 2022 72.0k
36 KINNATE BIOPHARMA INC COM KNTE KNTE 224,451 $2.8m0.77% 0.77% AddedShares held: Q3 2021 106.5k, Q4 2021 106.5k, Q1 2022 148.2k, Q2 2022 224.5k +76.3k +76,300 51.5%
37 AXOGEN INC COM AXGN AXGN 332,103 $2.7m0.74% 0.74% UnchangedShares held: Q3 2021 0, Q4 2021 332.1k, Q1 2022 332.1k, Q2 2022 332.1k
38 KALVISTA PHARMACEUTICALS INC COM KALV KALV 265,663 $2.6m0.71% 0.71% AddedShares held: Q3 2021 189.2k, Q4 2021 190.7k, Q1 2022 190.7k, Q2 2022 265.7k +75.0k +75,000 39.3%
39 89BIO INC COM ETNB ETNB 766,774 $2.5m0.67% 0.67% AddedShares held: Q3 2021 126.7k, Q4 2021 144.7k, Q1 2022 324.1k, Q2 2022 766.8k +442.7k +442,721 136.6%
40 DICE THERAPEUTICS INC COM COM 156,904 $2.4m0.66% 0.66% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 94.0k, Q2 2022 156.9k +62.9k +62,904 66.9%
41 GALAPAGOS NV SPON ADR LKFT LKFT 42,675 $2.4m0.65% 0.65% UnchangedShares held: Q3 2021 77.7k, Q4 2021 42.7k, Q1 2022 42.7k, Q2 2022 42.7k
42 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 131,200 $2.2m0.60% 0.60% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 53.2k, Q2 2022 131.2k +78.0k +78,000 146.6%
43 ITEOS THERAPEUTICS INC COM ITOS ITOS 105,298 $2.2m0.59% 0.59% AddedShares held: Q3 2021 83.1k, Q4 2021 54.1k, Q1 2022 89.3k, Q2 2022 105.3k +16.0k +16,000 17.9%
44 AERIE PHARMACEUTICALS INC COM AERI AERI 289,040 $2.2m0.59% 0.59% UnchangedShares held: Q3 2021 289.0k, Q4 2021 289.0k, Q1 2022 289.0k, Q2 2022 289.0k
45 KURA ONCOLOGY INC COM KURA KURA 117,829 $2.2m0.59% 0.59% AddedShares held: Q3 2021 100.8k, Q4 2021 110.8k, Q1 2022 113.3k, Q2 2022 117.8k +4.5k +4,500 4.0%
46 AFFIMED N V COM COM 686,282 $1.9m0.52% 0.52% AddedShares held: Q3 2021 964.9k, Q4 2021 571.3k, Q1 2022 571.3k, Q2 2022 686.3k +115.0k +115,000 20.1%
47 MERSANA THERAPEUTICS INC COM COM 406,763 $1.9m0.51% 0.51% AddedShares held: Q3 2021 140.3k, Q4 2021 140.3k, Q1 2022 352.8k, Q2 2022 406.8k +54.0k +54,000 15.3%
48 ORIC PHARMACEUTICALS INC COM ORIC ORIC 415,926 $1.9m0.51% 0.51% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 415.9k
49 ACCURAY INC COM ARAY ARAY 941,800 $1.8m0.50% 0.50% UnchangedShares held: Q3 2021 941.8k, Q4 2021 941.8k, Q1 2022 941.8k, Q2 2022 941.8k
50 SURFACE ONCOLOGY INC COM SURF SURF 1,100,000 $1.8m0.49% 0.49% AddedShares held: Q3 2021 0, Q4 2021 315.0k, Q1 2022 680.0k, Q2 2022 1.1m +420.0k +420,000 61.8%
51 BIOMEA FUSION INC COM BMEA BMEA 136,935 $1.6m0.45% 0.45% ReducedShares held: Q3 2021 0, Q4 2021 313.9k, Q1 2022 383.9k, Q2 2022 136.9k -247.0k -246,988 -64.3%
52 FIELD TRIP HEALTH LTD COM COM 1,904,141 $1.6m0.44% 0.44% ReducedShares held: Q3 2021 340.9k, Q4 2021 340.9k, Q1 2022 2.2m, Q2 2022 1.9m -287.2k -287,167 -13.1%
53 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 496,150 $1.4m0.38% 0.38% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 496.1k, Q2 2022 496.1k
54 PARDES BIOSCIENCES INC COM COM 451,105 $1.4m0.38% 0.38% AddedShares held: Q3 2021 0, Q4 2021 233.5k, Q1 2022 421.2k, Q2 2022 451.1k +29.9k +29,948 7.1%
55 NGM BIOPHARMACEUTICALS INC COM NGM NGM 107,653 $1.4m0.38% 0.38% UnchangedShares held: Q3 2021 65.5k, Q4 2021 80.5k, Q1 2022 107.7k, Q2 2022 107.7k
56 VIKING THERAPEUTICS INC COM VKTX VKTX 462,400 $1.3m0.36% 0.36% AddedShares held: Q3 2021 447.4k, Q4 2021 447.4k, Q1 2022 447.4k, Q2 2022 462.4k +15.0k +15,000 3.4%
57 AERIE PHARMACEUTICALS INC NOTE 1.500%10/0 · principal AERI 1.5 10.01.24 · principal AERI 1.5 10.01.24 1,500,000 $1.3m0.35% 0.35% UnchangedPrincipal held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
58 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 1,096,513 $1.2m0.33% 0.33% ReducedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.2m, Q2 2022 1.1m -120.1k -120,100 -9.9%
59 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 372,361 $1.2m0.33% 0.33% ReducedShares held: Q3 2021 0, Q4 2021 390.2k, Q1 2022 390.2k, Q2 2022 372.4k -17.8k -17,800 -4.6%
60 REGULUS THERAPEUTICS INC COM RGLS RGLS 555,555 $1.1m0.31% 0.31% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 555.6k
61 KEROS THERAPEUTICS INC COM KROS KROS 39,000 $1.1m0.29% 0.29% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 39.0k
62 MEI PHARMA INC COM NEW MEIP MEIP 1,767,146 $1.1m0.29% 0.29% UnchangedShares held: Q3 2021 641.0k, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 1.8m
63 NEURONETICS INC COM STIM STIM 313,717 $1.0m0.27% 0.27% UnchangedShares held: Q3 2021 313.7k, Q4 2021 313.7k, Q1 2022 313.7k, Q2 2022 313.7k
64 BRAINSWAY LTD SPONSORED ADS BWAY BWAY 200,000 $966.0k0.26% 0.26% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
65 RADIUS HEALTH INC COM NEW RDUS RDUS 91,935 $953.0k0.26% 0.26% ReducedShares held: Q3 2021 14.5k, Q4 2021 192.0k, Q1 2022 192.0k, Q2 2022 91.9k -100.0k -100,043 -52.1%
66 NEXTCURE INC COM COM 187,696 $882.0k0.24% 0.24% UnchangedShares held: Q3 2021 183.5k, Q4 2021 187.7k, Q1 2022 187.7k, Q2 2022 187.7k
67 SCYNEXIS INC COM NEW COM NEW 454,492 $845.0k0.23% 0.23% AddedShares held: Q3 2021 0, Q4 2021 121.2k, Q1 2022 121.2k, Q2 2022 454.5k +333.2k +333,250 274.9%
68 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 74,890 $810.0k0.22% 0.22% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 74.9k, Q2 2022 74.9k
69 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 313,600 $771.0k0.21% 0.21% UnchangedShares held: Q3 2021 0, Q4 2021 206.1k, Q1 2022 313.6k, Q2 2022 313.6k
70 GENFIT S A ADS GNFTY GNFTY 187,940 $605.0k0.16% 0.16% UnchangedShares held: Q3 2021 188.5k, Q4 2021 60.4k, Q1 2022 187.9k, Q2 2022 187.9k
71 ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAPY ADAPY 351,064 $597.0k0.16% 0.16% UnchangedShares held: Q3 2021 0, Q4 2021 136.3k, Q1 2022 351.1k, Q2 2022 351.1k
72 MACROGENICS INC COM MGNX MGNX 192,000 $566.0k0.15% 0.15% UnchangedShares held: Q3 2021 90.0k, Q4 2021 90.0k, Q1 2022 192.0k, Q2 2022 192.0k
73 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 55,000 $549.0k0.15% 0.15% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 55.0k, Q2 2022 55.0k
74 COMPASS THERAPEUTICS INC COM CMPX CMPX 198,094 $525.0k0.14% 0.14% AddedShares held: Q3 2021 0, Q4 2021 196.1k, Q1 2022 196.1k, Q2 2022 198.1k +2.0k +2,003 1.0%
75 THESEUS PHARMACEUTICALS INC COM COM 81,899 $453.0k0.12% 0.12% AddedShares held: Q3 2021 0, Q4 2021 97.5k, Q1 2022 80.1k, Q2 2022 81.9k +1.8k +1,775 2.2%
76 VENUS CONCEPT INC COM COM 968,187 $449.0k0.12% 0.12% UnchangedShares held: Q3 2021 1.1m, Q4 2021 975.7k, Q1 2022 968.2k, Q2 2022 968.2k
77 RIGEL PHARMACEUTICALS INC COM NEW COM NEW 390,066 $441.0k0.12% 0.12% ReducedShares held: Q3 2021 809.0k, Q4 2021 879.0k, Q1 2022 896.1k, Q2 2022 390.1k -506.0k -506,034 -56.5%
78 SUTRO BIOPHARMA INC COM COM 84,700 $441.0k0.12% 0.12% UnchangedShares held: Q3 2021 85.0k, Q4 2021 45.0k, Q1 2022 84.7k, Q2 2022 84.7k
79 MASIMO CORP COM MASI MASI 3,000 $392.0k0.11% 0.11% UnchangedShares held: Q3 2021 3.0k, Q4 2021 3.0k, Q1 2022 3.0k, Q2 2022 3.0k
80 COMPUGEN LTD ORD CGEN CGEN 205,202 $380.0k0.10% 0.10% AddedShares held: Q3 2021 201.5k, Q4 2021 201.5k, Q1 2022 130.2k, Q2 2022 205.2k +75.0k +75,000 57.6%
81 LAVA THERAPEUTICS NV SHS LVTX LVTX 128,335 $379.0k0.10% 0.10% ReducedShares held: Q3 2021 139.3k, Q4 2021 139.3k, Q1 2022 139.3k, Q2 2022 128.3k -11.0k -10,997 -7.9%
82 INOGEN INC COM INGN INGN 15,000 $363.0k0.10% 0.10% UnchangedShares held: Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k, Q2 2022 15.0k
83 VIGIL NEUROSCIENCE INC COM VIGL VIGL 99,754 $257.0k0.07% 0.07% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 99.8k, Q2 2022 99.8k
84 PHASEBIO PHARMACEUTICALS INC COM PHAS PHAS 378,611 $227.0k0.06% 0.06% UnchangedShares held: Q3 2021 603.0k, Q4 2021 378.6k, Q1 2022 378.6k, Q2 2022 378.6k
85 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 3,100 $222.0k0.06% 0.06% UnchangedShares held: Q3 2021 5.6k, Q4 2021 5.6k, Q1 2022 3.1k, Q2 2022 3.1k
86 LINEAGE CELL THERAPEUTICS IN COM LCTX LCTX 140,000 $221.0k0.06% 0.06% UnchangedShares held: Q3 2021 0, Q4 2021 80.0k, Q1 2022 140.0k, Q2 2022 140.0k
87 CONNECT BIOPHARMA HLDGS LTD ADS ADS 250,000 $218.0k0.06% 0.06% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 250.0k
88 ASLAN PHARMACEUTICALS LTD ADS ADS 343,720 $170.0k0.05% 0.05% AddedShares held: Q3 2021 732.5k, Q4 2021 732.5k, Q1 2022 243.7k, Q2 2022 343.7k +100.0k +100,000 41.0%
89 ANNEXON INC COM ANNX ANNX 40,796 $154.0k0.04% 0.04% AddedShares held: Q3 2021 23.3k, Q4 2021 30.8k, Q1 2022 30.8k, Q2 2022 40.8k +10.0k +10,000 32.5%
90 LARIMAR THERAPEUTICS INC COM LRMR LRMR 49,996 $98.0k0.03% 0.03% UnchangedShares held: Q3 2021 64.5k, Q4 2021 70.2k, Q1 2022 50.0k, Q2 2022 50.0k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
ATHIRA PHARMA INC 160,983 $2.2m161.0k shares
COGENT BIOSCIENCES INC COGT COGT 223,554 $1.7m223.6k shares
REGULUS THERAPEUTICS INC RGLS RGLS 5,555,555 $1.7m5.6m shares
IMMUNOCORE HLDGS PLC IMCR IMCR 53,878 $1.6m53.9k shares
PHARVARIS N V PHVS PHVS 34,615 $628.0k34.6k shares
HARPOON THERAPEUTICS INC 105,163 $523.0k105.2k shares
SURGALIGN HOLDINGS INC RTIX RTIX 579,710 $176.0k579.7k shares
INFINITY PHARMACEUTICALS INC INFIQ INFIQ 120,097 $137.0k120.1k shares